Laboratory researchers seeking to purchase ipamorelin can acquire high-purity, synthetic research-grade material through PX1 Research. Formulated exclusively for in vitro assays and preclinical models, our ipamorelin is manufactured in US-based, GMP-compliant facilities, backed by lot-specific third-party COA documentation via RP-HPLC and ESI-MS purity testing.
Laboratory researchers seeking to purchase ipamorelin can acquire high-purity, synthetic research-grade material through PX1 Research. Formulated exclusively for in vitro assays and preclinical models, our ipamorelin is manufactured in US-based, GMP-compliant facilities, backed by lot-specific third-party COA documentation via RP-HPLC and ESI-MS purity testing.
When procurement officers and principal investigators prepare to purchase ipamorelin for experimental protocols, validating chemical identity, batch consistency, and analytical purity is paramount. Scientific investigations focusing on growth hormone secretagogue receptor (GHS-R1a) activation demand reagents free from residual trifluoroacetic acid (TFA), truncated peptide sequences, or biological contaminants that could alter intracellular signaling assays.
PX1 Research supplies high-purity ipamorelin manufactured under strict quality systems in US-based facilities. Every lot is subjected to rigorous independent testing at ISO 17025 accredited laboratories, ensuring researchers receive fully characterized peptides supported by lot-specific Certificates of Analysis (COAs). Browse our full research peptides catalog to source laboratory-grade reagents engineered specifically for controlled academic and institutional studies.
Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2Nal-D-Phe-Lys-NH2 and a molecular weight of 711.86 g/mol. Incorporating the non-proteinogenic amino acid alpha-aminoisobutyric acid (Aib) at the N-terminus, the molecule exhibits enhanced enzymatic stability against aminopeptidase degradation compared to endogenous ghrelin peptides.
In solid-state peptide synthesis (SPSS), the deliberate inclusion of D-conformation amino acids (D-2-naphthylalanine and D-phenylalanine) establishes structural rigidification. Preclinical analytical models demonstrate that this specific spatial conformation optimizes binding kinetics to the ghrelin/growth hormone secretagogue receptor without interacting significantly with adjacent neuroendocrine receptors.
In vitro functional assays demonstrate that ipamorelin acts as a selective agonist at the growth hormone secretagogue receptor 1a (GHS-R1a), a G-protein coupled receptor predominantly expressed in the anterior pituitary gland and hypothalamus. Activation of GHS-R1a triggers the phospholipase C (PLC) signal transduction pathway, causing an intracellular influx of inositol trisphosphate (IP3) and subsequent calcium release from the endoplasmic reticulum.
Unlike earlier generations of secretagogues, preclinical data indicate that ipamorelin exhibits exceptional selectivity. In animal models, administration of ipamorelin stimulates pulsatile growth hormone (GH) release while causing negligible alterations in serum adrenocorticotropic hormone (ACTH), cortisol, prolactin, or aldosterone levels. This receptor specificity makes ipamorelin a valuable tool in cell culture and animal models designed to isolate the somatotrophic axis from broader stress-response cascades. Researchers can explore broader pathway mechanisms in our PX1 research library.
Investigational studies involving rodent models have demonstrated that ipamorelin promotes longitudinal bone growth, increases bone mineral density, and alters nitrogen balance without impairing baseline physiological feedback mechanisms. In vitro pituitocyte cultures demonstrate that the compound induces robust GH release in a dose-dependent manner, confirming its high intrinsic activity at target receptors.
Furthermore, preclinical evaluations in non-human primate and swine models indicate that ipamorelin preserves normal physiological GH secretion patterns, producing transient secretagogue pulses rather than continuous receptor activation. These observations are documented extensively in the broader literature surrounding growth hormone secretagogues, illustrating the compound's utility in studying metabolic rate, protein accrual mechanisms, and pituitary responsiveness.
When evaluating candidates for neuroendocrine research, investigators frequently compare ipamorelin against other GH secretagogues. First-generation compounds like GHRP-6 research compounds and GHRP-2 research peptides exhibit strong GH-releasing efficacy but routinely induce off-target stimulatory effects on prolactin and ACTH release. Additionally, GHRP-6 displays marked affinity for ghrelin-mediated appetite induction mechanisms in rodent models, whereas ipamorelin does not significantly alter feeding behavior.
Alternatively, investigators looking at GHRH-pathway synergism often evaluate ipamorelin alongside GHRH analogs such as CJC-1295 without DAC or Sermorelin research reagents. While GHRH analogs target the GHRH receptor via cyclic AMP elevation, ipamorelin operates distinctly through the GHS-R1a pathway via intracellular calcium mobilization, allowing researchers to explore dual-receptor activation paradigms in cell assays.
To guarantee experimental reproducibility, every batch of ipamorelin distributed by PX1 Research undergoes multi-point analytical verification. Purity is confirmed using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), where peak area integration must show greater than 99.0% purity. Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact monoisotopic mass and rules out deletion sequences or incomplete coupling products.
In addition to structural and chemical purity, PX1 Research evaluates biological safety parameters. Endotoxin levels are measured via Chromogenic Limulus Amebocyte Lysate (LAL) assays to confirm limits below 0.01 EU/mg, preventing endotoxin-induced inflammatory noise in cell assays. Institutional purchasers can review lot-specific COAs directly through our institutional wholesale program.
Ipamorelin is supplied as a sterile, lyophilized white powder to maximize shelf stability. For laboratory reconstitution, researchers should utilize sterile bacteriostatic water (0.9% benzyl alcohol) or sterile endotoxin-free phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream in vitro or ex vivo assay.
Reconstitution should be performed by gently running the diluent down the inner wall of the glass vial, followed by low-speed swirling. Mechanical agitation, vigorous shaking, or sonication must be avoided to prevent peptide shear stress and aggregate formation. Reconstituted solutions should be aliquoted into single-use polypropylene tubes to avoid repeated freeze-thaw cycles.
Desiccated lyophilized ipamorelin remains chemically stable at room temperature for brief transport periods, but long-term storage requires dedicated refrigeration parameters. Upon arrival at the laboratory facility, unopened vials should be stored at -20°C for up to 24 months, or at -80°C for extended archival storage.
Once reconstituted into aqueous solution, the peptide demonstrates optimal stability when stored at 2°C to 8°C for short-term experimentation (up to 30 days). For extended studies, reconstituted aliquots must be frozen at -20°C or lower. Light exposure and temperature fluctuations should be minimized to preserve peptide bond integrity.
PX1 Research is dedicated to supporting academic, biotechnology, and institutional research facilities across the United States. By standardizing domestic manufacturing, enforcing strict ISO 17025 third-party validation, and maintaining full lot traceability, we provide compounds that meet the exacting standards of peer-reviewed scientific inquiry.
Orders are fulfilled directly from our modern logistics centers located in California and Arizona, guaranteeing rapid turnaround times and same-day dispatch for orders placed before cutoff times. When your laboratory needs to purchase ipamorelin with guaranteed quality and reliable supply chains, PX1 Research delivers unmatched purity and analytical rigor.
How can I verify the analytical purity of ipamorelin prior to purchase?
Every lot of ipamorelin from PX1 Research is paired with a downloadable, lot-specific Certificate of Analysis (COA). Purity is independently verified via RP-HPLC, and molecular weight is verified via Mass Spectrometry (ESI-MS).
What is the molecular formula and weight of ipamorelin?
Ipamorelin has the chemical formula C38H49N9O5 and a molecular weight of 711.86 g/mol. Its sequence is Aib-His-D-2Nal-D-Phe-Lys-NH2.
How does ipamorelin differ from GHRP-2 and GHRP-6 in preclinical research?
Preclinical studies show that ipamorelin selectively activates the GHS-R1a receptor without elevating cortisol, prolactin, or ACTH levels. In contrast, GHRP-2 and GHRP-6 frequently induce non-selective elevations in these hormones.
What solvent is recommended for reconstituting lyophilized ipamorelin for lab assays?
Reconstitution is typically performed using sterile bacteriostatic water for multi-use laboratory applications, or sterile 0.9% saline/PBS for cell culture experiments. Solvent selection depends on specific experimental protocol design.
Are PX1 Research compounds intended for human clinical use?
No. All products sold by PX1 Research, including ipamorelin, are strictly for in vitro, cell culture, and preclinical laboratory research use only. They are not for human or animal clinical use, diagnosis, or therapy.
What endotoxin limits are maintained for PX1 Research peptides?
PX1 Research tests peptide lots using LAL chromogenic assays to ensure endotoxin levels remain below strictly monitored limits (typically <0.01 EU/mg), preventing cellular toxicity or artifactual inflammatory responses in research models.
How should lyophilized ipamorelin be stored upon receipt?
Unopened, lyophilized vials should be stored at -20°C or -80°C upon arrival. Protect vials from light and moisture exposure to maintain maximal chemical stability.
Does PX1 Research provide bulk or institutional purchasing options?
Yes. Institutional procurement officers and academic labs can set up wholesale lab accounts through our wholesale portal to access bulk pricing, dedicated account managers, and custom batch reservations.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.